tiletamine hydrochloride has been researched along with Cancer of Prostate in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YJ; Chung, CH; Hsueh, TY; Huang, TF; Lai, YW; Lin, CC; Lin, CH; Liu, SC; Wang, SW | 1 |
| Markaverich, BM; Rodriguez, MA; Shoulars, K; Thompson, T | 1 |
| Chang, FR; Chen, HM; Cheng, YJ; Hsieh, KC; Hsieh, YC; Lin, AS; Tsai, LM; Wu, YC; Yuan, SS | 1 |
| Gondo, T; Horiguchi, Y; Nakashima, J; Ohno, Y; Tachibana, M; Takeuchi, H | 1 |
| Hasegawa, M; Horiguchi, Y; Ide, H; Kikuchi, E; Kozakai, N; Miyajima, A; Nakashima, J; Oya, M; Shigematsu, N; Suzuki, E; Umezawa, K | 1 |
| Horiguchi, Y; Kikuchi, E; Kuroda, K; Murai, M; Nakashima, J; Ohigashi, T; Oya, M; Shima, Y; Takahashi, N; Umezawa, K | 1 |
| Campbell, WB; Endsley, MP; Falck, JR; Hillard, CJ; Isbell, MA; Iwamoto, Y; Nithipatikom, K | 1 |
| Horiguchi, Y; Kanao, K; Kikuchi, E; Kuroda, K; Miyajima, A; Murai, M; Nakashima, J; Ohigashi, T; Umezawa, K | 1 |
| Chang, HL; Su, JH; Wu, YC; Yeh, YT; Yuan, SS | 1 |
| Alejandro, MA; Markaverich, BM | 1 |
1 review(s) available for tiletamine hydrochloride and Cancer of Prostate
| Article | Year |
|---|---|
[NF-kappaB inhibitor].
Topics: Antineoplastic Agents; Benzamides; Cyclohexanones; Glucocorticoids; Humans; Male; NF-kappa B; Prostatic Neoplasms; Proteasome Inhibitors; Pyrrolidines; Thiocarbamates | 2011 |
9 other study(ies) available for tiletamine hydrochloride and Cancer of Prostate
| Article | Year |
|---|---|
4-Acetylantroquinonol B Suppresses Prostate Cancer Growth and Angiogenesis via a VEGF/PI3K/ERK/mTOR-Dependent Signaling Pathway in Subcutaneous Xenograft and In Vivo Angiogenesis Models.
Topics: 4-Butyrolactone; Angiogenesis Inhibitors; Cell Movement; Cell Proliferation; Cell Survival; Cyclohexanones; Gene Expression Regulation, Neoplastic; Human Umbilical Vein Endothelial Cells; Humans; Male; PC-3 Cells; Phosphatidylinositol 3-Kinase; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2022 |
Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.
Topics: Acetylation; Binding, Competitive; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Chromatin Immunoprecipitation; Cyclohexanones; DNA-Directed RNA Polymerases; Down-Regulation; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Growth Inhibitors; Histones; Humans; Luteolin; Male; Oligonucleotide Array Sequence Analysis; Polo-Like Kinase 1; Polymerase Chain Reaction; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Receptors, Estrogen; Transcription Factors, General; Up-Regulation | 2010 |
A novel synthetic protoapigenone analogue, WYC02-9, induces DNA damage and apoptosis in DU145 prostate cancer cells through generation of reactive oxygen species.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Caspase 3; Caspase 9; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 1; Checkpoint Kinase 2; Cyclohexanones; DNA Damage; Flavones; Gene Expression; Histones; Humans; Male; Membrane Potential, Mitochondrial; Mice; Mice, Nude; Mitochondria; Neoplasm Transplantation; Neoplasms, Experimental; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Protein Kinases; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2011 |
Enhancement of radiosensitivity by a unique novel NF-κB inhibitor, DHMEQ, in prostate cancer.
Topics: Animals; Antineoplastic Agents; Benzamides; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Cyclohexanones; Humans; Male; Mice; Mice, Nude; NF-kappa B; Prostatic Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Xenograft Model Antitumor Assays | 2012 |
Suppression of hormone-refractory prostate cancer by a novel nuclear factor kappaB inhibitor in nude mice.
Topics: Animals; Apoptosis; Benzamides; Cell Division; Cyclohexanones; Dose-Response Relationship, Drug; Drug Resistance; Humans; Kinetics; Male; Mice; Mice, Nude; NF-kappa B; Prostatic Neoplasms; Tumor Cells, Cultured | 2003 |
2-arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasion.
Topics: Androgens; Arachidonic Acids; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cyclohexanones; Endocannabinoids; Glycerides; Humans; Hydrolysis; Lipoprotein Lipase; Male; Neoplasm Invasiveness; Neoplasms, Hormone-Dependent; Prostatic Neoplasms; Receptor, Cannabinoid, CB1 | 2004 |
Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Topics: Albumins; Animals; Antineoplastic Agents; Benzamides; Body Mass Index; Body Weight; Cachexia; Cell Line, Tumor; Cyclohexanones; Disease Models, Animal; Dose-Response Relationship, Drug; Hematocrit; Humans; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Muscle, Skeletal; Neoplasm Transplantation; NF-kappa B; Prostatic Neoplasms; Time Factors; Triglycerides; Weight Loss | 2005 |
Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cyclohexanones; Flavones; Humans; Male; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays | 2008 |
Type II [3H]estradiol binding site antagonists: inhibition of normal and malignant prostate cell growth and proliferation.
Topics: Administration, Oral; Animals; Body Weight; Cell Division; Cyclohexanones; Estradiol; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Models, Biological; Organ Size; Prostate; Prostatic Neoplasms; Rats; Receptors, Estradiol; Seminal Vesicles; Testis; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |